1. Home
  2. OLN vs CRSP Comparison

OLN vs CRSP Comparison

Compare OLN & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

HOLD

Current Price

$22.21

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$56.95

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLN
CRSP
Founded
1892
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
5.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
OLN
CRSP
Price
$22.21
$56.95
Analyst Decision
Hold
Buy
Analyst Count
14
19
Target Price
$24.57
$71.50
AVG Volume (30 Days)
2.5M
2.2M
Earning Date
01-29-2026
11-10-2025
Dividend Yield
3.61%
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$6,787,000,000.00
$38,337,000.00
Revenue This Year
$3.82
N/A
Revenue Next Year
$2.15
$723.84
P/E Ratio
$47.66
N/A
Revenue Growth
4.68
N/A
52 Week Low
$17.66
$30.04
52 Week High
$39.14
$78.48

Technical Indicators

Market Signals
Indicator
OLN
CRSP
Relative Strength Index (RSI) 59.76 51.01
Support Level $20.00 $54.41
Resistance Level $21.80 $59.25
Average True Range (ATR) 0.88 2.92
MACD 0.29 0.87
Stochastic Oscillator 80.32 71.31

Price Performance

Historical Comparison
OLN
CRSP

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: